Back to Principal Financial Group Inc. Principal Financial Group Inc.

DNLIDNLI

Showing 9 of 29 quarters

Position history for Principal Financial Group Inc.Principal Financial Group Inc.'s holdings in Denali Therapeutics Inc.

Yes. Principal Financial Group holds 1,270,804 shares of DNLI (Denali Therapeutics), worth $26.3M, as of its Q3 2026 13F filing. It reduced the position by 149,279 shares (-10.5%) from Q2 2026. Principal Financial Group has held DNLI in every 13F on record since Q3 2019, 29 quarterly filings.

Current Value

$26.3M

Current Shares

1.3M

Total Value Change

-$9.8M

Total Shares Change

+32,328

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
1.3M
-10.5%
$26.3M0.0%$20.67
0
2026-Q2
Decreased
1.4M
-4.0%
$36.5M0.0%$25.72
0
2026-Q1
Decreased
1.5M
-3.0%
$28.4M0.0%$19.20
0
2025-Q4
Increased
1.5M
+19.9%
$25.2M0.0%$16.51
34
2025-Q3
Increased
1.3M
+18.5%
$18.5M0.0%$14.52
33
2025-Q2
Decreased
1.1M
-0.8%
$15M0.0%$13.99
0
2025-Q1
Decreased
1.1M
-4.4%
$14.7M0.0%$13.60
0
2024-Q4
Decreased
1.1M
-8.7%
$23M0.0%$20.38
0
2024-Q3
Increased
1.2M
+13.8%
$36.1M0.0%$29.43
33

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used